• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价:开发用于识别电子健康记录中肝硬化的共识代码集。

Systematic review: development of a consensus code set to identify cirrhosis in electronic health records.

机构信息

Leeds Liver Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.

出版信息

Aliment Pharmacol Ther. 2022 Mar;55(6):645-657. doi: 10.1111/apt.16806. Epub 2022 Feb 15.

DOI:10.1111/apt.16806
PMID:35166399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9302659/
Abstract

BACKGROUND

Electronic health records (EHRs) collate longitudinal data that can be used to facilitate large-scale research in patients with cirrhosis. However, there is no consensus code set to define the presence of cirrhosis in EHR. This systematic review aims to evaluate the validity of diagnostic coding in cirrhosis and to synthesise a comprehensive set of ICD-10 codes for future EHR research.

METHOD

MEDLINE and EMBASE databases were searched for studies that used EHR to identify cirrhosis and cirrhosis-related complications. Validated code sets were summarised, and the performance characteristics were extracted. Citation analysis was done to inform development of a consensus code set. This was then validated in a cohort of patients.

RESULTS

One thousand six hundred twenty-six records were screened, and 18 studies were identified. The positive predictive value (PPV) was the most frequently reported statistical estimate and was ≥80% in 17/18 studies. Citation analyses showed continued variation in those used in contemporary research practice. Nine codes were identified as those most frequently used in the literature and these formed the consensus code set. This was validated in diverse patient populations from Europe and North America and showed high PPV (83%-89%) and greater sensitivity for the identification of cirrhosis than the most often used code set in the recent literature.

CONCLUSION

There is variation in code sets used to identify cirrhosis in contemporary research practice. A consensus set has been developed and validated, showing improved performance, and is proposed to align EHR study designs in cirrhosis to facilitate international collaboration and comparisons.

摘要

背景

电子健康记录 (EHR) 可以整理出纵向数据,这些数据可用于促进肝硬化患者的大规模研究。然而,目前还没有共识的编码集来定义 EHR 中肝硬化的存在。本系统综述旨在评估肝硬化诊断编码的有效性,并为未来的 EHR 研究综合一套全面的 ICD-10 编码。

方法

在 MEDLINE 和 EMBASE 数据库中搜索使用 EHR 来识别肝硬化和肝硬化相关并发症的研究。总结了经过验证的编码集,并提取了性能特征。引文分析有助于制定共识编码集。然后在一组患者中验证了该编码集。

结果

共筛选出 1626 条记录,确定了 18 项研究。阳性预测值 (PPV) 是最常报告的统计估计值,在 17/18 项研究中≥80%。引文分析表明,目前研究实践中仍存在差异。确定了 9 个最常被文献使用的代码,这些代码构成了共识编码集。该编码集在来自欧洲和北美的不同患者群体中进行了验证,其阳性预测值 (83%-89%) 和肝硬化识别的敏感性均高于最近文献中最常用的编码集。

结论

目前在当代研究实践中,用于识别肝硬化的编码集存在差异。已经制定并验证了一套共识编码集,其性能有所提高,并建议用于肝硬化的 EHR 研究设计,以促进国际合作和比较。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1b/9302659/35b2d02e4822/APT-55-645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1b/9302659/35b2d02e4822/APT-55-645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae1b/9302659/35b2d02e4822/APT-55-645-g002.jpg

相似文献

1
Systematic review: development of a consensus code set to identify cirrhosis in electronic health records.系统评价:开发用于识别电子健康记录中肝硬化的共识代码集。
Aliment Pharmacol Ther. 2022 Mar;55(6):645-657. doi: 10.1111/apt.16806. Epub 2022 Feb 15.
2
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
6
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
8
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.

引用本文的文献

1
Validation of ICD-10 Consensus Code Set for Cirrhosis Detection Using Electronic Health Records in an Asian Population.在亚洲人群中使用电子健康记录验证用于肝硬化检测的ICD - 10共识编码集
JGH Open. 2025 May 6;9(5):e70156. doi: 10.1002/jgh3.70156. eCollection 2025 May.
2
Characterizing practice variations in the care of hospitalized patients with cirrhosis across the University of California Health.描述加州大学健康系统内肝硬化住院患者护理中的实践差异。
Liver Transpl. 2025 Apr 26. doi: 10.1097/LVT.0000000000000630.
3
Identifying emergency presentations of chronic liver disease using routinely collected administrative hospital data.

本文引用的文献

1
Validity of administrative codes associated with cirrhosis in Sweden.瑞典与肝硬化相关的行政编码的有效性。
Scand J Gastroenterol. 2020 Oct;55(10):1205-1210. doi: 10.1080/00365521.2020.1820566. Epub 2020 Sep 22.
2
Body composition predicts mortality and decompensation in compensated cirrhosis patients: A prospective cohort study.身体成分可预测代偿期肝硬化患者的死亡率和失代偿情况:一项前瞻性队列研究。
JHEP Rep. 2019 Dec 5;2(1):100061. doi: 10.1016/j.jhepr.2019.11.005. eCollection 2020 Feb.
3
Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study.
利用常规收集的医院管理数据识别慢性肝病的紧急情况。
JHEP Rep. 2024 Dec 31;7(5):101322. doi: 10.1016/j.jhepr.2024.101322. eCollection 2025 May.
4
Cirrhosis epidemiology in Denmark 1998-2022, and 2030 forecast.1998 - 2022年丹麦肝硬化流行病学及2030年预测。
JHEP Rep. 2025 Feb 8;7(5):101353. doi: 10.1016/j.jhepr.2025.101353. eCollection 2025 May.
5
Evidence-based criteria for identifying at-risk individuals requiring liver disease screening.用于识别需要进行肝病筛查的高危个体的循证标准。
Hepatol Commun. 2025 Mar 21;9(4). doi: 10.1097/HC9.0000000000000679. eCollection 2025 Apr 1.
6
Clinical Ethics Consultations in Cirrhosis Care.肝硬化护理中的临床伦理咨询
Dig Dis Sci. 2025 Mar;70(3):1008-1015. doi: 10.1007/s10620-025-08866-7. Epub 2025 Feb 8.
7
Real-World Trends and Future Projections of the Prevalence of Cirrhosis and Hepatic Encephalopathy Among Commercially and Medicare-Insured Adults in the United States.美国商业保险和医疗保险覆盖的成年人中肝硬化和肝性脑病患病率的真实世界趋势及未来预测
Clin Transl Gastroenterol. 2025 Jan 21;16(5). doi: 10.14309/ctg.0000000000000823.
8
Comparing the cost of cirrhosis to other common chronic diseases: A longitudinal study in a large national insurance database.肝硬化与其他常见慢性病的成本比较:一项基于大型 national 保险数据库的纵向研究。 注:原文中“national”前似乎少了个限定词,比如“national health”(国民健康)等,不然单独的“national”在这里语义不太完整。
Hepatology. 2025 Jan 6. doi: 10.1097/HEP.0000000000001206.
9
Contrasting rule and machine learning based digital self triage systems in the USA.对比美国基于规则和机器学习的数字自我分诊系统。
NPJ Digit Med. 2024 Dec 27;7(1):381. doi: 10.1038/s41746-024-01367-3.
10
High Hospitalization Rates and Risk Factors Among Frail Patients With Cirrhosis: A 10-year Population-based Cohort Study.肝硬化虚弱患者的高住院率及危险因素:一项基于人群的10年队列研究
Clin Gastroenterol Hepatol. 2024 Oct 18. doi: 10.1016/j.cgh.2024.08.044.
利用英格兰住院电子健康记录验证算法,以确定肝细胞癌患者中肝硬化的存在和严重程度:一项观察性研究。
BMJ Open. 2019 Jul 9;9(7):e028571. doi: 10.1136/bmjopen-2018-028571.
4
Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study.在卫生行政数据中识别肝硬化、失代偿性肝硬化和肝细胞癌:一项验证研究。
PLoS One. 2018 Aug 22;13(8):e0201120. doi: 10.1371/journal.pone.0201120. eCollection 2018.
5
Positive Predictive Value of International Classification of Diseases, 10th Revision, Codes for Cirrhosis and Its Related Complications.国际疾病分类第 10 版肝硬化及其相关并发症编码的阳性预测值。
Clin Gastroenterol Hepatol. 2018 Oct;16(10):1677-1678. doi: 10.1016/j.cgh.2018.01.042. Epub 2018 Feb 1.
6
Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records.使用诊断和程序编码通过电子健康记录识别失代偿性肝硬化的自动化算法的有效性
Clin Epidemiol. 2017 Jul 12;9:369-376. doi: 10.2147/CLEP.S136134. eCollection 2017.
7
Liver cirrhosis in England-an observational study: are we measuring its burden occurrence correctly?英国肝硬化——一项观察性研究:我们对其负担发生率的测量是否正确?
BMJ Open. 2017 Jul 13;7(7):e013752. doi: 10.1136/bmjopen-2016-013752.
8
The use of administrative health care databases to identify patients with rheumatoid arthritis.利用行政医疗保健数据库识别类风湿性关节炎患者。
Open Access Rheumatol. 2015 Nov 6;7:69-75. doi: 10.2147/OARRR.S92630. eCollection 2015.
9
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.1980 - 2015年全球、区域和国家249种死因的预期寿命、全死因死亡率和死因别死亡率:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.
10
Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations.对成人人群中ICD - 9编码和ICD - 10编码数据中糖尿病有效病例定义的系统评价。
BMJ Open. 2016 Aug 5;6(8):e009952. doi: 10.1136/bmjopen-2015-009952.